Pharmafile Logo
Pharmafocus logo
Advanced Search

PCKS9

Showing 3 posts of 3 posts found.

Amgen’s Repatha wins PCSK9 heart drug race

July 21, 2015
Sales and Marketing Amgen, European Commission, PCKS9, Repatha, evolocumab, high cholesterol

The European Commission has signed off on Amgen’s Repatha, making it the first in a new class of cholesterol-lowering drugs …

News
Logos

Praluent scores positive trial results in Japan

July 9, 2015
Research and Development Japan, PCKS9, Regeneron, Sanofi, heart disease, high cholesterol, praluent

Praluent, the new heart drug from Sanofi and Regeneron, has met its primary endpoint in a Phase III study in …

News

Sanofi/Regeneron cholesterol drug reaches Phase III

May 29, 2012
Research and Development, Sales and Marketing Amgen, PCKS9, Regeneron, SAR236553, Sanofi

Sanofi and Regeneron’s anti-cholesterol drug has impressed in a mid-stage trial, and will now progress into Phase III.  The firms’ …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024